Brief: Lipella Reports 2022 Loss Per Share Of $0.64
March 31 (Reuters) - Lipella Pharmaceuticals Inc
LIPO.O :
* LIPELLA PROVIDES BUSINESS UPDATE AND REPORTS 2022
FINANCIAL
RESULTS
* LIPELLA PHARMACEUTICALS INC - ENDED YEAR WITH $5.1 MILLION
IN
CASH
* LIPELLA PHARMACEUTICALS INC - ANTICIPATE CASH WILL PROVIDE
LIPELLA WITH AN OPERATING RUNWAY INTO 2024
Source text for Eikon: ID:nPn3kFm90a
Further company coverage: LIPO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lipella Pharmaceuticals
See all newsBrief: Lipella Pharmaceuticals Says Bankruptcy Court Approves Sale And Asset Purchase Agreement On June 4
Brief: Lipella Pharmaceuticals Inc. Files Voluntary Petitions For Relief Under Chapter 11
Brief: Lipella Pharmaceuticals Announces Positive Final Results From Phase 2a Study Of LP-10 In Oral Lichen Planus
Brief: Lipella Pharmaceuticals Announces Delisting From Nasdaq Capital Market
U.S. STOCKS ON THE MOVE-Marriott International, Coty, Carlyle Group